Tyrosine Phosphorylation of Caspase-8 Abrogates Its Apoptotic Activity and Promotes Activation of c-Src

Src family tyrosine kinases (SFKs) phosphorylate caspase-8A at tyrosine (Y) 397 resulting in suppression of apoptosis. In addition, the phosphorylation of caspase-8A at other sites including Y465 has been implicated in the regulation of caspase-8 activity. However, the functional consequences of these modifications on caspase-8 processing/activity have not been elucidated. Moreover, various Src substrates are known to act as potent Src regulators, but no such role has been explored for caspase-8. We asked whether the newly identified caspase-8 phosphorylation sites might regulate caspase-8 activation and conversely, whether caspase-8 phosphorylation might affect Src activity. Here we show that Src phosphorylates caspase-8A at multiple tyrosine sites; of these, we have focused on Y397 within the linker region and Y465 within the p12 subunit of caspase-8A. We show that phosphomimetic mutation of caspase-8A at Y465 prevents its cleavage and the subsequent activation of caspase-3 and suppresses apoptosis. Furthermore, simultaneous phosphomimetic mutation of caspase-8A at Y397 and Y465 promotes the phosphorylation of c-Src at Y416 and increases c-Src activity. Finally, we demonstrate that caspase-8 activity prevents its own tyrosine phosphorylation by Src. Together these data reveal that dual phosphorylation converts caspase-8 from a pro-apoptotic to a pro-survival mediator. Specifically, tyrosine phosphorylation by Src renders caspase-8 uncleavable and thereby inactive, and at the same time converts it to a Src activator. This novel dynamic interplay between Src and caspase-8 likely acts as a potent signal-integrating switch directing the cell towards apoptosis or survival.

[1]  Doris Berger The hunting of the src , 2014, Im Focus Onkologie.

[2]  D. Stupack,et al.  Rab5 Mediates Caspase-8–promoted Cell Motility and Metastasis , 2010, Molecular biology of the cell.

[3]  K. Vuori,et al.  Caspase-8 as a potential mediator of pro-tumorigenic signals , 2009, Cell cycle.

[4]  M. Butterworth,et al.  Reconstitution of the death-inducing signaling complex reveals a substrate switch that determines CD95-mediated death or survival. , 2009, Molecular cell.

[5]  K. Vuori,et al.  Critical role for caspase-8 in epidermal growth factor signaling. , 2009, Cancer research.

[6]  M. Grütter,et al.  Structural and biochemical studies on procaspase-8: new insights on initiator caspase activation. , 2009, Structure.

[7]  Deborah H Anderson,et al.  Caspase 8 Promotes Peripheral Localization and Activation of Rab5 , 2008, Journal of Biological Chemistry.

[8]  Yu Xue,et al.  GPS 2.0, a Tool to Predict Kinase-specific Phosphorylation Sites in Hierarchy *S , 2008, Molecular & Cellular Proteomics.

[9]  S. Janssens,et al.  Brief Definitive Report Stimulation of Toll-like Receptor 3 and 4 Induces Interleukin-1 ␤ Maturation by Caspase-8 , 2022 .

[10]  D. Stupack,et al.  Identification of a Critical Tyrosine Residue in Caspase 8 That Promotes Cell Migration* , 2008, Journal of Biological Chemistry.

[11]  John C. Marshall,et al.  Dynamic Regulation of Neutrophil Survival through Tyrosine Phosphorylation or Dephosphorylation of Caspase-8* , 2008, Journal of Biological Chemistry.

[12]  S. Frisch,et al.  Caspase-8 interacts with the p85 subunit of phosphatidylinositol 3-kinase to regulate cell adhesion and motility. , 2007, Cancer research.

[13]  K. Vuori,et al.  Novel noncatalytic role for caspase-8 in promoting SRC-mediated adhesion and Erk signaling in neuroblastoma cells. , 2007, Cancer research.

[14]  Mingyao Liu,et al.  XB130, a Novel Adaptor Protein for Signal Transduction* , 2007, Journal of Biological Chemistry.

[15]  R. Lotan,et al.  Identification and validation of differences in protein levels in normal, premalignant, and malignant lung cells and tissues using high-throughput Western Array and immunohistochemistry. , 2006, Cancer research.

[16]  Dong Sun Kim,et al.  Polymorphisms in the caspase-8 gene and the risk of lung cancer. , 2006, Cancer genetics and cytogenetics.

[17]  G. Superti-Furga,et al.  Src kinase phosphorylates Caspase‐8 on Tyr380: a novel mechanism of apoptosis suppression , 2006, The EMBO journal.

[18]  K. Vuori,et al.  Caspase-8 promotes cell motility and calpain activity under nonapoptotic conditions. , 2006, Cancer research.

[19]  P. Krammer,et al.  The role of CAP3 in CD95 signaling: new insights into the mechanism of procaspase-8 activation , 2006, Cell Death and Differentiation.

[20]  S. Adam‐Klages,et al.  The Fas-associated death domain protein/caspase-8/c-FLIP signaling pathway is involved in TNF-induced activation of ERK. , 2005, Experimental cell research.

[21]  L. Salmena,et al.  Requirement for Caspase-8 in NF-κB Activation by Antigen Receptor , 2005, Science.

[22]  W. Park,et al.  CASPASE-8 gene is inactivated by somatic mutations in gastric carcinomas. , 2005, Cancer research.

[23]  T. Boggon,et al.  Structure and regulation of Src family kinases , 2004, Oncogene.

[24]  G. Martin,et al.  The road to Src , 2004, Oncogene.

[25]  D. Kabelitz,et al.  Caspase Inhibition Blocks Human T Cell Proliferation by Suppressing Appropriate Regulation of IL-2, CD25, and Cell Cycle-Associated Proteins1 , 2004, The Journal of Immunology.

[26]  T. Kang,et al.  Caspase-8 Serves Both Apoptotic and Nonapoptotic Roles1 , 2004, The Journal of Immunology.

[27]  W. Park,et al.  Inactivating mutations of caspase-8 gene in colorectal carcinomas. , 2003, Gastroenterology.

[28]  D. Green,et al.  A unified model for apical caspase activation. , 2003, Molecular cell.

[29]  C. Briand,et al.  Insights into the regulatory mechanism for caspase-8 activation. , 2003, Molecular cell.

[30]  E. Avizienyte,et al.  Elevated c-Src is linked to altered cell–matrix adhesion rather than proliferation in KM12C human colorectal cancer cells , 2002, British Journal of Cancer.

[31]  Mingyao Liu,et al.  Molecular cloning of actin filament-associated protein: a putative adaptor in stretch-induced Src activation. , 2002, American journal of physiology. Lung cellular and molecular physiology.

[32]  M. Frame,et al.  Src in cancer: deregulation and consequences for cell behaviour. , 2002, Biochimica et biophysica acta.

[33]  John D Minna,et al.  Differential Inactivation of Caspase-8 in Lung Cancers , 2002, Cancer biology & therapy.

[34]  P. Auberger,et al.  Cleavage of Fyn and Lyn in their N-terminal unique regions during induction of apoptosis: a new mechanism for Src kinase regulation , 2001, Oncogene.

[35]  Y. Shiratori,et al.  Reduced C‐terminal Src kinase activity is correlated inversely with pp60c‐src activity in colorectal carcinoma , 2001, Cancer.

[36]  Martin Gs The hunting of the Src. , 2001 .

[37]  M. Gishizky,et al.  SU6656, a Selective Src Family Kinase Inhibitor, Used To Probe Growth Factor Signaling , 2000, Molecular and Cellular Biology.

[38]  T. Yeatman,et al.  Role of Src expression and activation in human cancer , 2000, Oncogene.

[39]  N. Hynes,et al.  Tyrosine kinase signalling in breast cancer , 2000, Breast Cancer Research.

[40]  Yoshihiro Nishioka,et al.  Mutation of the SRC Gene in Endometrial Carcinoma , 2000, Japanese journal of cancer research : Gann.

[41]  R. Sékaly,et al.  Early Activation of Caspases during T Lymphocyte Stimulation Results in Selective Substrate Cleavage in Nonapoptotic Cells , 1999, The Journal of experimental medicine.

[42]  J. Tschopp,et al.  Caspase Activation Is Required for T Cell Proliferation , 1999, The Journal of experimental medicine.

[43]  D. Schlaepfer,et al.  Signaling through focal adhesion kinase. , 1999, Progress in biophysics and molecular biology.

[44]  Y. Shiratori,et al.  Reduced C‐terminal Src kinase (Csk) activities in hepatocellular carcinoma , 1999, Hepatology.

[45]  Timothy J. Yeatman,et al.  Activating SRC mutation in a subset of advanced human colon cancers , 1999, Nature Genetics.

[46]  J. Blenis,et al.  Essential requirement for caspase-8/FLICE in the initiation of the Fas-induced apoptotic cascade , 1998, Current Biology.

[47]  V. Dixit,et al.  Death receptors: signaling and modulation. , 1998, Science.

[48]  J. Beckmann,et al.  Targeted disruption of the mouse Caspase 8 gene ablates cell death induction by the TNF receptors, Fas/Apo1, and DR3 and is lethal prenatally. , 1998, Immunity.

[49]  K. Matsumoto,et al.  pp60c‐src Activation in hepatocellular carcinoma of humans and LEC rats , 1998, Hepatology.

[50]  Matthias Mann,et al.  FLICE is activated by association with the CD95 death‐inducing signaling complex (DISC) , 1997, The EMBO journal.

[51]  V. Dixit,et al.  Fas-associated Death Domain Protein Interleukin-1β-converting Enzyme 2 (FLICE2), an ICE/Ced-3 Homologue, Is Proximally Involved in CD95- and p55-mediated Death Signaling* , 1997, The Journal of Biological Chemistry.

[52]  J. Bertin,et al.  Death effector domain-containing herpesvirus and poxvirus proteins inhibit both Fas- and TNFR1-induced apoptosis. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[53]  S. Srinivasula,et al.  Molecular ordering of the Fas-apoptotic pathway: the Fas/APO-1 protease Mch5 is a CrmA-inhibitable protease that activates multiple Ced-3/ICE-like cysteine proteases. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[54]  S. Srinivasula,et al.  In vitro activation of CPP32 and Mch3 by Mch4, a novel human apoptotic cysteine protease containing two FADD-like domains. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[55]  T. Hunter,et al.  Requirement for c-Src Catalytic Activity and the SH3 Domain in Platelet-derived Growth Factor BB and Epidermal Growth Factor Mitogenic Signaling* , 1996, The Journal of Biological Chemistry.

[56]  S. Courtneidge,et al.  The Src SH3 Domain Is Required for DNA Synthesis Induced by Platelet-derived Growth Factor and Epidermal Growth Factor* , 1996, The Journal of Biological Chemistry.

[57]  David Wallach,et al.  Involvement of MACH, a Novel MORT1/FADD-Interacting Protease, in Fas/APO-1- and TNF Receptor–Induced Cell Death , 1996, Cell.

[58]  Matthias Mann,et al.  FLICE, A Novel FADD-Homologous ICE/CED-3–like Protease, Is Recruited to the CD95 (Fas/APO-1) Death-Inducing Signaling Complex , 1996, Cell.

[59]  C. Cartwright,et al.  Src activity increases and Yes activity decreases during mitosis of human colon carcinoma cells , 1995, Molecular and cellular biology.

[60]  R. Pepperkok,et al.  The Src family tyrosine kinases are required for platelet-derived growth factor-mediated signal transduction in NIH 3T3 cells. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[61]  I Nicoletti,et al.  A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry. , 1991, Journal of immunological methods.

[62]  T. Kmiecik,et al.  Activation and suppression of pp60c-src transforming ability by mutation of its primary sites of tyrosine phosphorylation , 1987, Cell.

[63]  H. Oppermann,et al.  Characterization of sites for tyrosine phosphorylation in the transforming protein of Rous sarcoma virus (pp60v-src) and its normal cellular homologue (pp60c-src). , 1981, Proceedings of the National Academy of Sciences of the United States of America.

[64]  Samir Guglani Death , 1890, The Lancet.

[65]  L. Salmena,et al.  Requirement for caspase-8 in NF-kappaB activation by antigen receptor. , 2005, Science.

[66]  Peter F Thall,et al.  Activated SRC protein tyrosine kinase is overexpressed in late-stage human ovarian cancers. , 2003, Gynecologic oncology.

[67]  A Krueger,et al.  The active caspase-8 heterotetramer is formed at the CD95 DISC , 2003, Cell Death and Differentiation.